MPS NOVA is an EU Horizon Twinning project led by the Instituto de Tecnologia Química e Biológica (ITQB NOVA) in collaboration with NOVA Medical School (NMS). The goal of the project is to establish a European Hub of Excellence in Microphysiological Systems (MPS), leveraging pluripotent stem cell technologies to enhance the research and innovation capacity of Universidade Nova de Lisboa (UNL).
MPS_NOVA focuses on developing advanced methodologies to study chronic diseases and host-microbe interactions, utilizing cutting-edge human-relevant systems like organ-on-a-chip devices.
MPS NOVA unites key expertise from partner institutions across Europe:
UNL - extensive experience in biomedical research models.
Universitätsklinikum Jena (UKJ, Germany) - pioneering research in MPS systems.
Fondazione Human Technopole (FHT, Italy) - leading innovations in pluripotent stem cell technologies.
Max Delbrück Center for Molecular Medicine (MDC, Germany) - advanced integrative metabolomics and proteomics tailored for MPS applications.
Together, these partners are forging the future of disease modeling!
Company Details
- Founded
- -
- Address
- Online Via Teams
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://mpsnova.itqb.unl.pt/
Mps_nova Twinning Questions
Mps_Nova Twinning's website is https://mpsnova.itqb.unl.pt/
Mps_Nova Twinning's LinkedIn profile is https://www.linkedin.com/company/mps-nova-twinning
Mps_Nova Twinning's industry is
Biotechnology Research
Mps_Nova Twinning's top competitors are
Gimm,
European Federation Of Biotechnology,
Innovantibiofilm,
Ls4future Associate Laboratory,
Silicolife,
Genexis Biotech,
Ibb-Institute For Bioengineering And Biosciences,
Nimsb - Nova Institute For Medical Systems Biology,
Fairjourney Biologics,
Genética Médica.
Mps_Nova Twinning's categories are Biotechnology Research
Mps_Nova Twinning's founding year is 2024
